213 related articles for article (PubMed ID: 28782476)
21. Acute coronary syndrome induced by capecitabine therapy.
Wijesinghe N; Thompson PI; McAlister H
Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
[TBL] [Abstract][Full Text] [Related]
22. Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.
Mitani S; Kadowaki S; Komori A; Sugiyama K; Narita Y; Taniguchi H; Ura T; Ando M; Sato Y; Yamaura H; Inaba Y; Ishihara M; Tanaka T; Tajika M; Muro K
Medicine (Baltimore); 2017 Jun; 96(22):e6874. PubMed ID: 28562536
[TBL] [Abstract][Full Text] [Related]
23. [A Case of Consciousness Disturbance Caused by Hyperammonemia during a mFOLFOX6 Regimen for Metastatic Colon Cancer].
Kagawa Y; Kato T; Naito A; Murakami K; Katsura Y; Ohmura Y; Okishiro M; Takeno A; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2160-2. PubMed ID: 26805297
[TBL] [Abstract][Full Text] [Related]
24. Treatment of advanced colorectal cancer in a patient with cardiotoxic reactions to 5-fluorouracil and capecitabine using suboptimal doses.
Cioffi JH; Estes DJ; Florou V; Ardalan B
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29183892
[TBL] [Abstract][Full Text] [Related]
25. 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey.
Boilève A; Thomas L; Lillo-Le Louët A; Gaboriau L; Chouchana L; Ducreux M; Malka D; Boige V; Hollebecque A; Hillaire-Buys D; Jozwiak M
Eur J Cancer; 2020 Apr; 129():32-40. PubMed ID: 32120273
[TBL] [Abstract][Full Text] [Related]
26. Capecitabine-induced myopericarditis - A case report and review of literature.
Saunders S; Anwar M
J Oncol Pharm Pract; 2019 Jun; 25(4):1006-1010. PubMed ID: 29783917
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson's disease worsened after capecitabine therapy.
Badzek S; Miletic V; Prejac J; Gorsic I; Golem H; Bilic E; Kekez D; Librenjak N; Plestina S
World J Surg Oncol; 2013 Sep; 11():224. PubMed ID: 24028681
[TBL] [Abstract][Full Text] [Related]
28. Capecitabine-induced acute toxic leukoencephalopathy.
Obadia M; Leclercq D; Wasserman J; Galanaud D; Dormont D; Sahli-Amor M; Psimaras D; Pyatigorskaya N; Law-Ye B
Neurotoxicology; 2017 Sep; 62():1-5. PubMed ID: 28487252
[TBL] [Abstract][Full Text] [Related]
29. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
[TBL] [Abstract][Full Text] [Related]
30. [A Case of Disturbance of Consciousness Due to Hyperammonemia during Chemotherapy for Metastasis of Sigmoid Colon Cancer].
Kaizaki R; Inoue T; Eguchi S; Nishiyama T; Nobori C; Kunimoto T; Okazaki Y; Takatsuka S; Tsukamoto T; Nishiguchi Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1777-1779. PubMed ID: 33468826
[TBL] [Abstract][Full Text] [Related]
31. [Study of tolerability of capecitabine in postoperative adjuvant chemotherapy in colon cancer].
Matsuda C; Tamagawa H; Nishikawa K; Deguchi T; Kawata J; Iwase K; Takagi M; Fukui A; Nezu R; Tanaka Y
Gan To Kagaku Ryoho; 2013 Mar; 40(3):327-30. PubMed ID: 23507593
[TBL] [Abstract][Full Text] [Related]
32. Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis.
Nikolic-Tomasevic Z; Jelic S; Cassidy J; Filipovic-Ljeskovic I; Tomasevic Z
Cancer Chemother Pharmacol; 2005 Dec; 56(6):594-602. PubMed ID: 16044340
[TBL] [Abstract][Full Text] [Related]
33. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
[TBL] [Abstract][Full Text] [Related]
34. Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide.
Shumar J; Junga Z; Johnson JT; Goldkind L
BMJ Case Rep; 2019 Dec; 12(11):. PubMed ID: 31791985
[TBL] [Abstract][Full Text] [Related]
35. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
Do JE; Kim YC
Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
[TBL] [Abstract][Full Text] [Related]
36. Capecitabine-warfarin interaction.
Janney LM; Waterbury NV
Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
[TBL] [Abstract][Full Text] [Related]
37. Capecitabine and sixth cranial nerve palsy.
Dasgupta S; Adilieje C; Bhattacharya A; Smith B; Sheikh Mu
J Cancer Res Ther; 2010; 6(1):80-1. PubMed ID: 20479552
[TBL] [Abstract][Full Text] [Related]
38. Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.
Twelves CJ
Clin Colorectal Cancer; 2006 Nov; 6(4):278-87. PubMed ID: 17241512
[TBL] [Abstract][Full Text] [Related]
39. Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice.
Phua VC; Wong WQ; Tan PL; Bustam AZ; Saad M; Alip A; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(4):1449-53. PubMed ID: 25743814
[TBL] [Abstract][Full Text] [Related]
40. Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.
Godinho J; Casa-Nova M; Mesquita T; Baptista MJ; Araújo F; Vale J; Passos Coelho JL
J Oncol Pharm Pract; 2019 Mar; 25(2):497-501. PubMed ID: 29121830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
